Johannes Attems, MD - Publications

Pathology Newcastle University, Newcastle upon Tyne, England, United Kingdom 
Neurodegenerative diseases

130 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Attems J, Toledo JB, Walker L, Gelpi E, Gentleman S, Halliday G, Hortobagyi T, Jellinger K, Kovacs GG, Lee EB, Love S, McAleese KE, Nelson PT, Neumann M, Parkkinen L, et al. Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study. Acta Neuropathologica. PMID 33399945 DOI: 10.1007/s00401-020-02255-2  0.32
2020 McAleese KE, Walker L, Erskine D, Johnson M, Koss D, Thomas AJ, Attems J. Concomitant LATE-NC in Alzheimer's disease is not associated with increased tau or amyloid-β pathological burden. Neuropathology and Applied Neurobiology. PMID 32896913 DOI: 10.1111/nan.12664  0.32
2020 Neddens J, Daurer M, Flunkert S, Beutl K, Loeffler T, Walker L, Attems J, Hutter-Paier B. Correlation of pyroglutamate amyloid β and ptau Ser202/Thr205 levels in Alzheimer's disease and related murine models. Plos One. 15: e0235543. PMID 32645028 DOI: 10.1371/journal.pone.0235543  0.32
2020 Kurzawa-Akanbi M, Keogh M, Tsefou E, Ramsay L, Johnson M, Keers S, Ochieng LW, McNair A, Singh P, Khan A, Pyle A, Hudson G, Ince PG, Attems J, Burn J, et al. Neuropathological and biochemical investigation of Hereditary Ferritinopathycases with ferritin light chain mutation: Prominent protein aggregation in the absence of major mitochondrial or oxidative stress. Neuropathology and Applied Neurobiology. PMID 32464705 DOI: 10.1111/nan.12634  0.32
2020 Marschallinger J, Altendorfer B, Rockenstein E, Holztrattner M, Garnweidner-Raith J, Pillichshammer N, Leister I, Hutter-Paier B, Strempfl K, Unger MS, Chishty M, Felder T, Johnson M, Attems J, Masliah E, et al. The Leukotriene Receptor Antagonist Montelukast Reduces Alpha-Synuclein Load and Restores Memory in an Animal Model of Dementia with Lewy Bodies. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 32072462 DOI: 10.1007/s13311-020-00836-3  0.32
2019 Walker L, Attems J. Relationship Between Tau, β Amyloid and α-Synuclein Pathologies. Advances in Experimental Medicine and Biology. 1184: 169-176. PMID 32096037 DOI: 10.1007/978-981-32-9358-8_14  0.32
2019 Prokopenko I, Miyakawa G, Zheng B, Heikkinen J, Petrova Quayle D, Udeh-Momoh C, Claringbould A, Neumann J, Haytural H, Kaakinen MA, Loizidou E, Meissner E, Bertram L, Gveric DO, ... ... Attems J, et al. Alzheimer's disease pathology explains association between dementia with Lewy bodies and APOE-ε4/TOMM40 long poly-T repeat allele variants. Alzheimer's & Dementia (New York, N. Y.). 5: 814-824. PMID 31788537 DOI: 10.1016/j.trci.2019.08.005  0.32
2019 Alexandris AS, Walker L, Liu AKL, McAleese K, Johnson M, Pearce RKB, Gentleman SM, Attems J. Cholinergic deficits and galaninergic hyperinnervation of the nucleus basalis of Meynert in Alzheimer's disease and Lewy body disorders. Neuropathology and Applied Neurobiology. PMID 31454423 DOI: 10.1111/nan.12577  0.32
2019 Szegő ÉM, Dominguez-Meijide A, Gerhardt E, König A, Koss DJ, Li W, Pinho R, Fahlbusch C, Johnson M, Santos P, Villar-Piqué A, Thom T, Rizzoli S, Schmitz M, Li J, ... ... Attems J, et al. Cytosolic Trapping of a Mitochondrial Heat Shock Protein Is an Early Pathological Event in Synucleinopathies. Cell Reports. 28: 65-77.e6. PMID 31269451 DOI: 10.1016/j.celrep.2019.06.009  0.32
2019 Walker L, Stefanis L, Attems J. Clinical and neuropathological differences between Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies - current issues and future directions. Journal of Neurochemistry. PMID 30892688 DOI: 10.1111/jnc.14698  0.32
2019 Walker L, McAleese KE, Erskine D, Attems J. Neurodegenerative Diseases and Ageing. Sub-Cellular Biochemistry. 91: 75-106. PMID 30888650 DOI: 10.1007/978-981-13-3681-2_4  0.32
2019 Outeiro TF, Koss DJ, Erskine D, Walker L, Kurzawa-Akanbi M, Burn D, Donaghy P, Morris C, Taylor JP, Thomas A, Attems J, McKeith I. Dementia with Lewy bodies: an update and outlook. Molecular Neurodegeneration. 14: 5. PMID 30665447 DOI: 10.1186/s13024-019-0306-8  0.32
2018 McAleese KE, Graham S, Dey M, Walker L, Erskine D, Johnson M, Johnston E, Thomas AJ, McKeith IG, DeCarli C, Attems J. Extravascular fibrinogen in the white matter of Alzheimer's disease and normal aged brains: implications for fibrinogen as a biomarker for Alzheimer's disease. Brain Pathology (Zurich, Switzerland). PMID 30485582 DOI: 10.1111/bpa.12685  0.32
2018 Keogh MJ, Wei W, Aryaman J, Walker L, van den Ameele J, Coxhead J, Wilson I, Bashton M, Beck J, West J, Chen R, Haudenschild C, Bartha G, Luo S, Morris CM, ... ... Attems J, et al. High prevalence of focal and multi-focal somatic genetic variants in the human brain. Nature Communications. 9: 4257. PMID 30323172 DOI: 10.1038/s41467-018-06331-w  0.32
2018 McAleese KE, Walker L, Colloby SJ, Taylor JP, Thomas AJ, DeCarli C, Attems J. Cortical tau pathology: a major player in fibre-specific white matter reductions in Alzheimer's disease? Brain : a Journal of Neurology. PMID 29668888 DOI: 10.1093/brain/awy084  0.32
2018 Unger MS, Marschallinger J, Kaindl J, Klein B, Johnson M, Khundakar AA, Roßner S, Heneka MT, Couillard-Despres S, Rockenstein E, Masliah E, Attems J, Aigner L. Doublecortin expression in CD8+ T-cells and microglia at sites of amyloid-β plaques: A potential role in shaping plaque pathology? Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29630865 DOI: 10.1016/j.jalz.2018.02.017  0.32
2018 Thomas AJ, Mahin-Babaei F, Saidi M, Lett D, Taylor JP, Walker L, Attems J. Improving the identification of dementia with Lewy bodies in the context of an Alzheimer's-type dementia. Alzheimer's Research & Therapy. 10: 27. PMID 29490691 DOI: 10.1186/s13195-018-0356-0  0.32
2018 Gatt A, Ekonomou A, Somani A, Thuret S, Howlett D, Corbett A, Johnson M, Perry E, Attems J, Francis P, Aarsland D, Ballard C. Importance of Proactive Treatment of Depression in Lewy Body Dementias: The Impact on Hippocampal Neurogenesis and Cognition in a Post-Mortem Study. Dementia and Geriatric Cognitive Disorders. 44: 283-293. PMID 29393203 DOI: 10.1159/000484437  0.32
2017 McAleese KE, Walker L, Graham S, Moya ELJ, Johnson M, Erskine D, Colloby SJ, Dey M, Martin-Ruiz C, Taylor JP, Thomas AJ, McKeith IG, De Carli C, Attems J. Parietal white matter lesions in Alzheimer's disease are associated with cortical neurodegenerative pathology, but not with small vessel disease. Acta Neuropathologica. PMID 28638989 DOI: 10.1007/s00401-017-1738-2  0.32
2017 Kovacs GG, Xie SX, Lee EB, Robinson JL, Caswell C, Irwin DJ, Toledo JB, Johnson VE, Smith DH, Alafuzoff I, Attems J, Bencze J, Bieniek KF, Bigio EH, Bodi I, et al. Multisite Assessment of Aging-Related Tau Astrogliopathy (ARTAG). Journal of Neuropathology and Experimental Neurology. PMID 28591867 DOI: 10.1093/jnen/nlx041  0.32
2017 Walker L, McAleese KE, Johnson M, Khundakar AA, Erskine D, Thomas AJ, McKeith IG, Attems J. Quantitative neuropathology: an update on automated methodologies and implications for large scale cohorts. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 28265813 DOI: 10.1007/s00702-017-1702-2  0.32
2016 Robinson AC, Palmer L, Love S, Hamard M, Esiri M, Ansorge O, Lett D, Attems J, Morris C, Troakes C, Selvackadunco S, King A, Al-Sarraj S, Mann DM. Extended post-mortem delay times should not be viewed as a deterrent to the scientific investigation of human brain tissue: a study from the Brains for Dementia Research Network Neuropathology Study Group, UK. Acta Neuropathologica. PMID 27638700 DOI: 10.1007/s00401-016-1617-2  1
2016 Manousopoulou A, Gatherer M, Smith C, Nicoll JA, Woelk CH, Johnson M, Kalaria R, Attems J, Garbis SD, Carare RO. Systems proteomic analysis reveals that Clusterin and Tissue Inhibitor of Metalloproteinases 3 increase in leptomeningeal arteries affected by cerebral amyloid angiopathy. Neuropathology and Applied Neurobiology. PMID 27543695 DOI: 10.1111/nan.12342  0.32
2016 McAleese KE, Walker L, Erskine D, Thomas AJ, McKeith IG, Attems J. TDP-43 Pathology in Alzheimer's Disease, Dementia with Lewy Bodies, and Ageing. Brain Pathology (Zurich, Switzerland). PMID 27495267 DOI: 10.1111/bpa.12424  0.32
2016 Keogh MJ, Kurzawa-Akanbi M, Griffin H, Douroudis K, Ayers KL, Hussein RI, Hudson G, Pyle A, Cordell HJ, Attems J, McKeith IG, O'Brien JT, Burn DJ, Morris CM, Thomas AJ, et al. Exome sequencing in dementia with Lewy bodies. Translational Psychiatry. 6: e728. PMID 26836416 DOI: 10.1038/tp.2015.220  1
2016 Maj M, Hoermann G, Rasul S, Base W, Wagner L, Attems J. The Microtubule-Associated Protein Tau and Its Relevance for Pancreatic Beta Cells. Journal of Diabetes Research. 2016: 1964634. PMID 26824039 DOI: 10.1155/2016/1964634  1
2015 Kovacs GG, Ferrer I, Grinberg LT, Alafuzoff I, Attems J, Budka H, Cairns NJ, Crary JF, Duyckaerts C, Ghetti B, Halliday GM, Ironside JW, Love S, Mackenzie IR, Munoz DG, et al. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathologica. PMID 26659578 DOI: 10.1007/s00401-015-1509-x  1
2015 Vallortigara J, Whitfield D, Quelch W, Alghamdi A, Howlett D, Hortobágyi T, Johnson M, Attems J, O'Brien JT, Thomas A, Ballard CG, Aarsland D, Francis PT. Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia. Journal of Alzheimer's Disease : Jad. PMID 26639969 DOI: 10.3233/JAD-150707  1
2015 Lee C, Low CY, Francis PT, Attems J, Wong PT, Lai MK, Tan MG. An isoform-specific role of FynT tyrosine kinase in Alzheimer's disease. Journal of Neurochemistry. PMID 26561212 DOI: 10.1111/jnc.13429  1
2015 McAleese KE, Firbank M, Dey M, Colloby SJ, Walker L, Johnson M, Beverley JR, Taylor JP, Thomas AJ, O'Brien JT, Attems J. Cortical tau load is associated with white matter hyperintensities. Acta Neuropathologica Communications. 3: 60. PMID 26419828 DOI: 10.1186/s40478-015-0240-0  0.32
2015 Ziso B, Williams TL, Walters RJ, Jaiser SR, Attems J, Wieshmann UC, Larner AJ, Jacob A. Facial Onset Sensory and Motor Neuronopathy: Further Evidence for a TDP-43 Proteinopathy. Case Reports in Neurology. 7: 95-100. PMID 26327906 DOI: 10.1159/000381944  1
2015 Keable A, Fenna K, Yuen HM, Johnston DA, Smyth NR, Smith C, Salman RA, Samarasekera N, Nicoll JA, Attems J, Kalaria RN, Weller RO, Carare RO. Deposition of amyloid β in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy. Biochimica Et Biophysica Acta. PMID 26327684 DOI: 10.1016/j.bbadis.2015.08.024  1
2015 Baek JH, Whitfield D, Howlett D, Francis P, Bereczki E, Ballard C, Hortobágyi T, Attems J, Aarsland D. Unfolded protein response is activated in Lewy body dementias. Neuropathology and Applied Neurobiology. PMID 26202523 DOI: 10.1111/nan.12260  1
2015 Attems J, Walker L, Jellinger KA. Olfaction and Aging: A Mini-Review. Gerontology. PMID 25968962 DOI: 10.1159/000381619  1
2015 Erskine D, Taylor JP, Firbank MJ, Patterson L, Onofrj M, O'Brien JT, McKeith IG, Attems J, Thomas AJ, Morris CM, Khundakar AA. Changes to the lateral geniculate nucleus in Alzheimer's disease but not dementia with Lewy bodies. Neuropathology and Applied Neurobiology. PMID 25967384 DOI: 10.1111/nan.12249  1
2015 Howlett DR, Attems J, Francis PT. Spreading pathologies precede cognitive decline in Alzheimer's disease. Biological Psychiatry. 77: 678-9. PMID 25835285 DOI: 10.1016/j.biopsych.2015.02.001  1
2015 Jellinger KA, Alafuzoff I, Attems J, Beach TG, Cairns NJ, Crary JF, Dickson DW, Hof PR, Hyman BT, Jack CR, Jicha GA, Knopman DS, Kovacs GG, Mackenzie IR, Masliah E, et al. PART, a distinct tauopathy, different from classical sporadic Alzheimer disease. Acta Neuropathologica. 129: 757-62. PMID 25778618 DOI: 10.1007/s00401-015-1407-2  1
2015 Walker L, McAleese KE, Thomas AJ, Johnson M, Martin-Ruiz C, Parker C, Colloby SJ, Jellinger K, Attems J. Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes. Acta Neuropathologica. 129: 729-48. PMID 25758940 DOI: 10.1007/s00401-015-1406-3  1
2015 Spilsbury A, Miwa S, Attems J, Saretzki G. The role of telomerase protein TERT in Alzheimer's disease and in tau-related pathology in vitro. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 1659-74. PMID 25632141 DOI: 10.1523/JNEUROSCI.2925-14.2015  1
2015 Thal DR, von Arnim CA, Griffin WS, Mrak RE, Walker L, Attems J, Arzberger T. Frontotemporal lobar degeneration FTLD-tau: preclinical lesions, vascular, and Alzheimer-related co-pathologies. Journal of Neural Transmission (Vienna, Austria : 1996). 122: 1007-18. PMID 25556950 DOI: 10.1007/s00702-014-1360-6  1
2015 Tiraboschi P, Attems J, Thomas A, Brown A, Jaros E, Lett DJ, Ossola M, Perry RH, Ramsay L, Walker L, McKeith IG. Clinicians' ability to diagnose dementia with Lewy bodies is not affected by β-amyloid load. Neurology. 84: 496-9. PMID 25552579 DOI: 10.1212/WNL.0000000000001204  1
2015 Howlett DR, Whitfield D, Johnson M, Attems J, O'Brien JT, Aarsland D, Lai MK, Lee JH, Chen C, Ballard C, Hortobágyi T, Francis PT. Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias. Brain Pathology (Zurich, Switzerland). 25: 401-8. PMID 25103200 DOI: 10.1111/bpa.12182  1
2015 Jellinger KA, Attems J. Challenges of multimorbidity of the aging brain: a critical update. Journal of Neural Transmission (Vienna, Austria : 1996). 122: 505-21. PMID 25091618 DOI: 10.1007/s00702-014-1288-x  1
2015 Ekonomou A, Savva GM, Brayne C, Forster G, Francis PT, Johnson M, Perry EK, Attems J, Somani A, Minger SL, Ballard CG. Stage-specific changes in neurogenic and glial markers in Alzheimer's disease. Biological Psychiatry. 77: 711-9. PMID 25022604 DOI: 10.1016/j.biopsych.2014.05.021  1
2014 Vallortigara J, Rangarajan S, Whitfield D, Alghamdi A, Howlett D, Hortobágyi T, Johnson M, Attems J, Ballard C, Thomas A, O'Brien J, Aarsland D, Francis P. Dynamin1 concentration in the prefrontal cortex is associated with cognitive impairment in Lewy body dementia. F1000research. 3: 108. PMID 25671083 DOI: 10.12688/f1000research.3786.1  1
2014 Attems J, Neltner JH, Nelson PT. Quantitative neuropathological assessment to investigate cerebral multi-morbidity. Alzheimer's Research & Therapy. 6: 85. PMID 25435922 DOI: 10.1186/s13195-014-0085-y  1
2014 Attems J, Jellinger KA. The overlap between vascular disease and Alzheimer's disease--lessons from pathology. Bmc Medicine. 12: 206. PMID 25385447 DOI: 10.1186/s12916-014-0206-2  1
2014 Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, Arnold SE, Attems J, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Gearing M, Grinberg LT, Hof PR, et al. Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathologica. 128: 755-66. PMID 25348064 DOI: 10.1007/s00401-014-1349-0  1
2014 Veitinger M, Oehler R, Umlauf E, Baumgartner R, Schmidt G, Gerner C, Babeluk R, Attems J, Mitulovic G, Rappold E, Lamont J, Zellner M. A platelet protein biochip rapidly detects an Alzheimer's disease-specific phenotype. Acta Neuropathologica. 128: 665-77. PMID 25248508 DOI: 10.1007/s00401-014-1341-8  1
2014 Thal DR, Attems J, Ewers M. Spreading of amyloid, tau, and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies. Journal of Alzheimer's Disease : Jad. 42: S421-9. PMID 25227313 DOI: 10.3233/JAD-141461  1
2014 Whitfield DR, Vallortigara J, Alghamdi A, Howlett D, Hortobágyi T, Johnson M, Attems J, Newhouse S, Ballard C, Thomas AJ, O'Brien JT, Aarsland D, Francis PT. Assessment of ZnT3 and PSD95 protein levels in Lewy body dementias and Alzheimer's disease: association with cognitive impairment. Neurobiology of Aging. 35: 2836-44. PMID 25104558 DOI: 10.1016/j.neurobiolaging.2014.06.015  1
2014 Ferrari R, Hernandez DG, Nalls MA, Rohrer JD, Ramasamy A, Kwok JB, Dobson-Stone C, Brooks WS, Schofield PR, Halliday GM, Hodges JR, Piguet O, Bartley L, Thompson E, Haan E, ... ... Attems J, et al. Frontotemporal dementia and its subtypes: a genome-wide association study. The Lancet. Neurology. 13: 686-99. PMID 24943344 DOI: 10.1016/S1474-4422(14)70065-1  1
2014 Mandler M, Walker L, Santic R, Hanson P, Upadhaya AR, Colloby SJ, Morris CM, Thal DR, Thomas AJ, Schneeberger A, Attems J. Pyroglutamylated amyloid-β is associated with hyperphosphorylated tau and severity of Alzheimer's disease. Acta Neuropathologica. 128: 67-79. PMID 24861310 DOI: 10.1007/s00401-014-1296-9  1
2014 Schreiber S, Drukarch B, Garz C, Niklass S, Stanaszek L, Kropf S, Bueche C, Held F, Vielhaber S, Attems J, Reymann KG, Heinze HJ, Carare RO, Wilhelmus MM. Interplay between age, cerebral small vessel disease, parenchymal amyloid-β, and tau pathology: longitudinal studies in hypertensive stroke-prone rats. Journal of Alzheimer's Disease : Jad. 42: S205-15. PMID 24825568 DOI: 10.3233/JAD-132618  1
2014 Vergani F, Lacerda L, Martino J, Attems J, Morris C, Mitchell P, Thiebaut de Schotten M, Dell'Acqua F. White matter connections of the supplementary motor area in humans. Journal of Neurology, Neurosurgery, and Psychiatry. 85: 1377-85. PMID 24741063 DOI: 10.1136/jnnp-2013-307492  1
2014 Attems J, Walker L, Jellinger KA. Olfactory bulb involvement in neurodegenerative diseases. Acta Neuropathologica. 127: 459-75. PMID 24554308 DOI: 10.1007/s00401-014-1261-7  1
2014 Fuchs EM, Köstler WJ, Horvat R, Hudelist G, Kubista E, Attems J, Zielinski CC, Singer CF. High-level ERBB2 gene amplification is associated with a particularly short time-to-metastasis, but results in a high rate of complete response once trastuzumab-based therapy is offered in the metastatic setting. International Journal of Cancer. Journal International Du Cancer. 135: 224-31. PMID 24311197 DOI: 10.1002/ijc.28660  1
2013 Thal DR, von Arnim C, Griffin WS, Yamaguchi H, Mrak RE, Attems J, Upadhaya AR. Pathology of clinical and preclinical Alzheimer's disease. European Archives of Psychiatry and Clinical Neuroscience. 263: S137-45. PMID 24077890 DOI: 10.1007/s00406-013-0449-5  1
2013 Attems J, Jellinger KA. Amyloid and tau: neither chicken nor egg but two partners in crime! Acta Neuropathologica. 126: 619-21. PMID 23955601 DOI: 10.1007/s00401-013-1167-9  1
2013 Akinyemi RO, Mukaetova-Ladinska EB, Attems J, Ihara M, Kalaria RN. Vascular risk factors and neurodegeneration in ageing related dementias: Alzheimer's disease and vascular dementia. Current Alzheimer Research. 10: 642-53. PMID 23627757 DOI: 10.2174/15672050113109990037  1
2013 Attems J, Jellinger K. Neuropathological correlates of cerebral multimorbidity. Current Alzheimer Research. 10: 569-77. PMID 23627751 DOI: 10.2174/15672050113109990002  1
2013 Yamamoto Y, Craggs LJ, Watanabe A, Booth T, Attems J, Low RW, Oakley AE, Kalaria RN. Brain microvascular accumulation and distribution of the NOTCH3 ectodomain and granular osmiophilic material in CADASIL. Journal of Neuropathology and Experimental Neurology. 72: 416-31. PMID 23584202 DOI: 10.1097/NEN.0b013e31829020b5  1
2013 Jellinger KA, Attems J. Neuropathological approaches to cerebral aging and neuroplasticity. Dialogues in Clinical Neuroscience. 15: 29-43. PMID 23576887  1
2013 McAleese KE, Firbank M, Hunter D, Sun L, Hall R, Neal JW, Mann DM, Esiri M, Jellinger KA, O'Brien JT, Attems J. Magnetic resonance imaging of fixed post mortem brains reliably reflects subcortical vascular pathology of frontal, parietal and occipital white matter. Neuropathology and Applied Neurobiology. 39: 485-97. PMID 23075072 DOI: 10.1111/j.1365-2990.2012.01310.x  1
2013 Lendvai D, Morawski M, Négyessy L, Gáti G, Jäger C, Baksa G, Glasz T, Attems J, Tanila H, Arendt T, Harkany T, Alpár A. Neurochemical mapping of the human hippocampus reveals perisynaptic matrix around functional synapses in Alzheimer's disease. Acta Neuropathologica. 125: 215-29. PMID 22961619 DOI: 10.1007/s00401-012-1042-0  1
2012 Colloby SJ, McParland S, O'Brien JT, Attems J. Neuropathological correlates of dopaminergic imaging in Alzheimer's disease and Lewy body dementias. Brain : a Journal of Neurology. 135: 2798-808. PMID 22961551 DOI: 10.1093/brain/aws211  1
2012 Jellinger KA, Attems J. Nigral pathology in older persons without Parkinson disease. Annals of Neurology. 72: 297; author reply 29. PMID 22926864 DOI: 10.1002/ana.23640  1
2012 Attems J, Thal DR, Jellinger KA. The relationship between subcortical tau pathology and Alzheimer's disease. Biochemical Society Transactions. 40: 711-5. PMID 22817721 DOI: 10.1042/BST20120034  1
2012 Alafuzoff I, Gelpi E, Al-Sarraj S, Arzberger T, Attems J, Bodi I, Bogdanovic N, Budka H, Bugiani O, Englund E, Ferrer I, Gentleman S, Giaccone G, Graeber MB, Hortobagyi T, et al. The need to unify neuropathological assessments of vascular alterations in the ageing brain: multicentre survey by the BrainNet Europe consortium. Experimental Gerontology. 47: 825-33. PMID 22705312 DOI: 10.1016/j.exger.2012.06.001  1
2012 Thal DR, Grinberg LT, Attems J. Vascular dementia: different forms of vessel disorders contribute to the development of dementia in the elderly brain. Experimental Gerontology. 47: 816-24. PMID 22705146 DOI: 10.1016/j.exger.2012.05.023  1
2012 Perry EK, Johnson M, Ekonomou A, Perry RH, Ballard C, Attems J. Neurogenic abnormalities in Alzheimer's disease differ between stages of neurogenesis and are partly related to cholinergic pathology. Neurobiology of Disease. 47: 155-62. PMID 22504537 DOI: 10.1016/j.nbd.2012.03.033  1
2012 Attems J, Alpar A, Spence L, McParland S, Heikenwalder M, Uhlén M, Tanila H, Hökfelt TG, Harkany T. Clusters of secretagogin-expressing neurons in the aged human olfactory tract lack terminal differentiation. Proceedings of the National Academy of Sciences of the United States of America. 109: 6259-64. PMID 22474393 DOI: 10.1073/pnas.1203843109  1
2012 Jellinger KA, Attems J. Neuropathology and general autopsy findings in nondemented aged subjects. Clinical Neuropathology. 31: 87-98. PMID 22385790  1
2012 Watabe-Rudolph M, Song Z, Lausser L, Schnack C, Begus-Nahrmann Y, Scheithauer MO, Rettinger G, Otto M, Tumani H, Thal DR, Attems J, Jellinger KA, Kestler HA, von Arnim CA, Rudolph KL. Chitinase enzyme activity in CSF is a powerful biomarker of Alzheimer disease. Neurology. 78: 569-77. PMID 22323746 DOI: 10.1212/WNL.0b013e318247caa1  1
2012 Zellner M, Baureder M, Rappold E, Bugert P, Kotzailias N, Babeluk R, Baumgartner R, Attems J, Gerner C, Jellinger K, Roth E, Oehler R, Umlauf E. Comparative platelet proteome analysis reveals an increase of monoamine oxidase-B protein expression in Alzheimer's disease but not in non-demented Parkinson's disease patients. Journal of Proteomics. 75: 2080-92. PMID 22270014 DOI: 10.1016/j.jprot.2012.01.014  1
2012 Attems J, Thomas A, Jellinger K. Correlations between cortical and subcortical tau pathology. Neuropathology and Applied Neurobiology. 38: 582-90. PMID 22115520 DOI: 10.1111/j.1365-2990.2011.01244.x  1
2012 Alpár A, Attems J, Mulder J, Hökfelt T, Harkany T. The renaissance of Ca2+-binding proteins in the nervous system: secretagogin takes center stage. Cellular Signalling. 24: 378-87. PMID 21982882 DOI: 10.1016/j.cellsig.2011.09.028  1
2011 Jellinger KA, Attems J. Rapidly progressing diffuse Lewy body disease. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 2584-5; author reply. PMID 22038930 DOI: 10.1002/mds.23976  1
2011 Lassmann H, Bancher C, Attems J, Paulus W. In honor of the 80th birthday of Kurt Jellinger: a living legend in neuropathology. Acta Neuropathologica. 121: 565-8. PMID 21523431 DOI: 10.1007/s00401-011-0827-x  1
2011 Jellinger KA, Attems J. Prevalence and pathology of dementia with Lewy bodies in the oldest old: a comparison with other dementing disorders. Dementia and Geriatric Cognitive Disorders. 31: 309-16. PMID 21502762 DOI: 10.1159/000327360  1
2011 Attems J, Ittner A, Jellinger K, Nitsch RM, Maj M, Wagner L, Götz J, Heikenwalder M. Reduced secretagogin expression in the hippocampus of P301L tau transgenic mice. Journal of Neural Transmission (Vienna, Austria : 1996). 118: 737-45. PMID 21442354 DOI: 10.1007/s00702-011-0626-5  1
2011 Kovacs GG, Wöhrer A, Ströbel T, Botond G, Attems J, Budka H. Unclassifiable tauopathy associated with an A152T variation in MAPT exon 7. Clinical Neuropathology. 30: 3-10. PMID 21176711 DOI: 10.5414/NPP30003  1
2011 Attems J, Jellinger K, Thal DR, Van Nostrand W. Review: sporadic cerebral amyloid angiopathy. Neuropathology and Applied Neurobiology. 37: 75-93. PMID 20946241 DOI: 10.1111/j.1365-2990.2010.01137.x  1
2011 Attems J, Jellinger KA. Pathologic aspects of the hemorrhagic consequences of small vessel disease on the brain Cerebral Small Vessel Disease. 29-41. DOI: 10.1017/CBO9781139382694.005  1
2011 Watzka SB, Köstler WJ, Attems J. Reply to Mordant et al European Journal of Cardio-Thoracic Surgery. 39: 428. DOI: 10.1016/j.ejcts.2010.06.025  1
2010 Jellinger KA, Attems J. Prevalence and pathology of vascular dementia in the oldest-old. Journal of Alzheimer's Disease : Jad. 21: 1283-93. PMID 21504129 DOI: 10.3233/JAD-2010-100603  1
2010 Jellinger KA, Attems J. Is there pure vascular dementia in old age? Journal of the Neurological Sciences. 299: 150-4. PMID 20869729 DOI: 10.1016/j.jns.2010.08.038  1
2010 Attems J, Yamaguchi H, Saido TC, Thal DR. Capillary CAA and perivascular Aβ-deposition: two distinct features of Alzheimer's disease pathology. Journal of the Neurological Sciences. 299: 155-62. PMID 20850138 DOI: 10.1016/j.jns.2010.08.030  1
2010 Thal DR, Papassotiropoulos A, Saido TC, Griffin WS, Mrak RE, Kölsch H, Del Tredici K, Attems J, Ghebremedhin E. Capillary cerebral amyloid angiopathy identifies a distinct APOE epsilon4-associated subtype of sporadic Alzheimer's disease. Acta Neuropathologica. 120: 169-83. PMID 20535486 DOI: 10.1007/s00401-010-0707-9  1
2010 Watzka SB, Rauscher-Pötsch I, Nierlich P, Setinek U, Köstler WJ, Pötschger U, Müller MR, Attems J. Concordance between epidermal growth factor receptor status in primary non-small-cell lung cancer and metastases: a post-mortem study. European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association For Cardio-Thoracic Surgery. 38: 34-7. PMID 20353893 DOI: 10.1016/j.ejcts.2010.01.023  1
2010 Jellinger KA, Attems J. Prevalence of dementia disorders in the oldest-old: an autopsy study. Acta Neuropathologica. 119: 421-33. PMID 20204386 DOI: 10.1007/s00401-010-0654-5  1
2010 Maj M, Gartner W, Ilhan A, Neziri D, Attems J, Wagner L. Expression of TAU in insulin-secreting cells and its interaction with the calcium-binding protein secretagogin. The Journal of Endocrinology. 205: 25-36. PMID 20061514 DOI: 10.1677/JOE-09-0341  1
2009 Dimou E, Booij J, Rodrigues M, Prosch H, Attems J, Knoll P, Zajicek B, Dudczak R, Mostbeck G, Kuntner C, Langer O, Bruecke T, Mirzaei S. Amyloid PET and MRI in Alzheimer's disease and mild cognitive impairment. Current Alzheimer Research. 6: 312-9. PMID 19519314 DOI: 10.2174/156720509788486563  1
2008 Armbruster C, Huber M, Prosch H, Dworan N, Attems J. Ewing's sarcoma and peripheral primitive neuroectodermal tumor in adults: different features of a rare neoplasm. Onkologie. 31: 179-84. PMID 18418019 DOI: 10.1159/000118034  1
2008 Jellinger KA, Janetzky B, Attems J, Kienzl E. Biomarkers for early diagnosis of Alzheimer disease: 'ALZheimer ASsociated gene'--a new blood biomarker? Journal of Cellular and Molecular Medicine. 12: 1094-117. PMID 18363842 DOI: 10.1111/j.1582-4934.2008.00313.x  1
2008 Jellinger KA, Attems J. Cerebral amyloid angiopathy in Lewy body disease. Journal of Neural Transmission (Vienna, Austria : 1996). 115: 473-82. PMID 18301958 DOI: 10.1007/s00702-007-0856-8  1
2008 Attems J, Jellinger KA. The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease. Neuropathology and Applied Neurobiology. 34: 466-7. PMID 18282157 DOI: 10.1111/j.1365-2990.2008.00937.x  1
2008 Jellinger KA, Attems J. Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease. Acta Neuropathologica. 115: 427-36. PMID 18273624 DOI: 10.1007/s00401-008-0347-5  1
2008 Attems J, Lauda F, Jellinger KA. Unexpectedly low prevalence of intracerebral hemorrhages in sporadic cerebral amyloid angiopathy: an autopsy study. Journal of Neurology. 255: 70-6. PMID 18202817 DOI: 10.1007/s00415-008-0674-4  1
2008 Attems J, Preusser M, Grosinger-Quass M, Wagner L, Lintner F, Jellinger K. Calcium-binding protein secretagogin-expressing neurones in the human hippocampus are largely resistant to neurodegeneration in Alzheimer's disease. Neuropathology and Applied Neurobiology. 34: 23-32. PMID 17961140 DOI: 10.1111/j.1365-2990.2007.00854.x  1
2008 Jellinger KA, Attems J. The role of vascular and Alzheimer pathologies in Lewy body disease | Die rolle von vaskulären und Alzheimerläsionen bei Lewy-körper-krankheiten Journal Fur Neurologie, Neurochirurgie Und Psychiatrie. 9: 7-10.  1
2007 Huber M, Rumetshofer R, Stradal KH, Attems J, Lintner F. Catheter-related Leuconostoc bacteremia secondary to pulmonary Mycobacterium xenopi infection. Wiener Klinische Wochenschrift. 119: 674-7. PMID 18043889 DOI: 10.1007/s00508-007-0848-6  1
2007 Jellinger KA, Lauda F, Attems J. Sporadic cerebral amyloid angiopathy is not a frequent cause of spontaneous brain hemorrhage. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 14: 923-8. PMID 17662016 DOI: 10.1111/j.1468-1331.2007.01880.x  1
2007 Sutterlüty H, Mayer CE, Setinek U, Attems J, Ovtcharov S, Mikula M, Mikulits W, Micksche M, Berger W. Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms. Molecular Cancer Research : McR. 5: 509-20. PMID 17510316 DOI: 10.1158/1541-7786.MCR-06-0273  1
2007 Jellinger KA, Attems J. Neuropathological evaluation of mixed dementia. Journal of the Neurological Sciences. 257: 80-7. PMID 17324442 DOI: 10.1016/j.jns.2007.01.045  1
2007 Attems J, Quass M, Jellinger KA, Lintner F. Topographical distribution of cerebral amyloid angiopathy and its effect on cognitive decline are influenced by Alzheimer disease pathology. Journal of the Neurological Sciences. 257: 49-55. PMID 17306303 DOI: 10.1016/j.jns.2007.01.013  1
2007 Attems J, Quass M, Gartner W, Nabokikh A, Wagner L, Steurer S, Arbes S, Lintner F, Jellinger K. Immunoreactivity of calcium binding protein secretagogin in the human hippocampus is restricted to pyramidal neurons. Experimental Gerontology. 42: 215-22. PMID 17116382 DOI: 10.1016/j.exger.2006.09.018  0.44
2007 Jellinger KA, Attems J. Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease. Acta Neuropathologica. 113: 107-17. PMID 17089134 DOI: 10.1007/s00401-006-0156-7  1
2007 Attems J, Quass M, Jellinger KA. Tau and alpha-synuclein brainstem pathology in Alzheimer disease: relation with extrapyramidal signs. Acta Neuropathologica. 113: 53-62. PMID 17031655 DOI: 10.1007/s00401-006-0146-9  1
2006 Attems J, Jellinger KA. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment. Clinical Neuropathology. 25: 265-71. PMID 17140156  1
2006 Jellinger KA, Attems J. Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies? Acta Neuropathologica. 112: 253-60. PMID 16804711 DOI: 10.1007/s00401-006-0088-2  1
2006 Huber M, Pohl W, Reinisch G, Attems J, Pescosta S, Lintner F. Lung disease 35 years after aspiration of activated charcoal in combination with pulmonary lymphangioleiomyomatosis. A histological and clinicopathological study with scanning electron microscopic evaluation and element analysis. Virchows Archiv : An International Journal of Pathology. 449: 225-9. PMID 16775697 DOI: 10.1007/s00428-006-0236-z  1
2006 Jellinger KA, Attems J. Prevalence and impact of cerebrovascular pathology in Alzheimer's disease and parkinsonism. Acta Neurologica Scandinavica. 114: 38-46. PMID 16774626 DOI: 10.1111/j.1600-0404.2006.00665.x  1
2006 Attems J, Jellinger KA. Hippocampal sclerosis in Alzheimer disease and other dementias. Neurology. 66: 775. PMID 16534130 DOI: 10.1212/01.wnl.0000200959.50898.26  1
2006 Hudelist G, Köstler WJ, Czerwenka K, Kubista E, Attems J, Müller R, Gschwantler-Kaulich D, Manavi M, Huber I, Hoschützky H, Zielinski CC, Singer CF. Her-2/neu and EGFR tyrosine kinase activation predict the efficacy of trastuzumab-based therapy in patients with metastatic breast cancer. International Journal of Cancer. Journal International Du Cancer. 118: 1126-34. PMID 16161043 DOI: 10.1002/ijc.21492  1
2005 Attems J. Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms. Acta Neuropathologica. 110: 345-59. PMID 16170565 DOI: 10.1007/s00401-005-1074-9  1
2005 Attems J, König C, Huber M, Lintner F, Jellinger KA. Cause of death in demented and non-demented elderly inpatients; an autopsy study of 308 cases. Journal of Alzheimer's Disease : Jad. 8: 57-62. PMID 16155350  1
2005 Attems J, Jellinger KA, Lintner F. Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy. Acta Neuropathologica. 110: 222-31. PMID 16133541 DOI: 10.1007/s00401-005-1064-y  1
2005 Köstler WJ, Brodowicz T, Hudelist G, Rudas M, Horvat R, Steger GG, Singer CF, Attems J, Rabitsch W, Fakhrai N, Elandt K, Wiltschke C, Hejna M, Zielinski CC. The efficacy of trastuzumab in Her-2/neu-overexpressing metastatic breast cancer is independent of p53 status. Journal of Cancer Research and Clinical Oncology. 131: 420-8. PMID 15864644 DOI: 10.1007/s00432-005-0670-3  1
2005 Berger W, Setinek U, Hollaus P, Zidek T, Steiner E, Elbling L, Cantonati H, Attems J, Gsur A, Micksche M. Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications. Journal of Cancer Research and Clinical Oncology. 131: 355-63. PMID 15856298 DOI: 10.1007/s00432-004-0653-9  1
2005 Attems J, Lintner F, Jellinger KA. Olfactory involvement in aging and Alzheimer's disease: an autopsy study. Journal of Alzheimer's Disease : Jad. 7: 149-57; discussion 1. PMID 15851853  1
2005 Jellinger KA, Attems J. Alzheimer pathology in the olfactory bulb. Neuropathology and Applied Neurobiology. 31: 203. PMID 15771713 DOI: 10.1111/j.1365-2990.2004.00619.x  1
2005 Jellinger KA, Attems J. Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease. Journal of the Neurological Sciences. 229: 37-41. PMID 15760617 DOI: 10.1016/j.jns.2004.11.018  1
2004 Attems J, Arbes S, Böhm G, Böhmer F, Lintner F. The clinical diagnostic accuracy rate regarding the immediate cause of death in a hospitalized geriatric population; an autopsy study of 1594 patients. Wiener Medizinische Wochenschrift (1946). 154: 159-62. PMID 15182042 DOI: 10.1007/s10354-004-0057-0  1
2004 Attems J, Lintner F, Jellinger KA. Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology. Acta Neuropathologica. 107: 283-91. PMID 14986026 DOI: 10.1007/s00401-004-0822-6  1
2004 Attems J, Jellinger KA. Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology--a pilot study. Acta Neuropathologica. 107: 83-90. PMID 14655019 DOI: 10.1007/s00401-003-0796-9  1
2003 Hudelist G, Köstler WJ, Attems J, Czerwenka K, Müller R, Manavi M, Steger GG, Kubista E, Zielinski CC, Singer CF. Her-2/neu-triggered intracellular tyrosine kinase activation: in vivo relevance of ligand-independent activation mechanisms and impact upon the efficacy of trastuzumab-based treatment. British Journal of Cancer. 89: 983-91. PMID 12966413 DOI: 10.1038/sj.bjc.6601160  1
2003 Jellinger KA, Attems J. Incidence of cerebrovascular lesions in Alzheimer's disease: a postmortem study. Acta Neuropathologica. 105: 14-7. PMID 12471455 DOI: 10.1007/s00401-002-0634-5  1
2001 Attems JH, Lintner F. Pseudomesotheliomatous adenocarcinoma of the lung with rhabdoid features. Pathology, Research and Practice. 197: 841-6. PMID 11795833 DOI: 10.1078/0344-0338-00170  1
2001 Attems JH, Huber M, Hollaus P, Lintner F. HER2 expression and HER2/neu amplification in bronchial biopsy specimens of non-small cell lung cancer Langenbeck's Archives of Surgery. 386: 454-455.  0.32
Show low-probability matches.